This paper gives an overview of placebo-controlled studies of the effe
ct of corticosteroid treatment on nasal blockage, based on objective m
easurements of nasal airway patency. A few studies of perennial rhinit
is have indicated that pretreatment with an intranasal corticosteroid
has a moderate effect on nasal hyperresponsiveness, measured as the hi
stamine-induced increase of nasal blockage. Whereas the effect on alle
rgen-induced early-phase symptoms is variable, the effect on the late-
phase blockage is almost complete. In seasonal allergic rhinitis, a fe
w studies have shown an effect of intranasal steroids on nasal airway
resistance, nasal peak flow and on acoustic rhinometry, but there are
no reports on the effect in adults with perennial rhinitis. In childre
n with perennial disease, intranasal treatment results in increased na
sal patency and, in one study, also in reduced mouth breathing and in
an increased threshold for exercise-induced bronchoconstriction. In pa
tients with nasal polyposis, intranasal steroids have an effect on nas
al airway resistance and on nasal peak flow both before and after poly
pectomy. There is convincing evidence that intranasal corticosteroids
provide a better effect than antihistamine on nasal blockage. Amazingl
y, there does not appear to be any report on the effect of systemic co
rticosteroid treatment on nasal airway patency, and it is therefore di
fficult to recommend this treatment in a rational dosage. In conclusio
n, there is a fairly good documentation in support of the efficacy of
intranasal steroid treatment on nasal airway patency in rhinitis. An o
bjective measurement of nasal airway patency ought to be the routine i
n controlled rhinitis trials.